Pharmacotherapy and smoking cessation at a tobacco dependence clinic

Michael B. Steinberg, Jonathan Foulds, Donna L. Richardson, Michael V. Burke, Pooja Shah

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background. Tobacco dependence medications are effective, and combinations may offer advantages. This study evaluates abstinence rates among smokers treated in a tobacco specialist clinic with individual and/or group counseling plus combination pharmacotherapy. Methods. 790 smokers treated at the Tobacco Dependence Clinic in New Jersey from 2001-2003 and contacted 4 weeks after quit-date were studied. Patients received medications and behavioral interventions. Abstinence over the previous 7 days was evaluated at 4 weeks and 6 months. Patients lost to 6-month follow-up were considered still smoking. Results. Overall, 36% of patients were abstinent at 6 months (20% who used no medications, 37% using one medication, 37% using 2 medications, 42% using 3 medications, and 42% using 4+ medications) (P = 0.017). 27% still used medications at 6 months, and had higher abstinence rates (65%) than those who stopped their medications (27%) (P < 0.001). Number of medications predicted abstinence at 4 weeks [adjusted odds ratios = 2.30 (95% CI; 1.27-4.18) for 1 medication, 4.78 (2.72-8.40) for 2 medications, 5.83 (2.98-11.40) for 3 medications, and 11.80 (4.10-33.95) for 4+ medications]. Increasing age, increasing level of education, longer time after waking to first cigarette, more than 7 clinical contacts, and more medications used were related to higher abstinence at 6 months. Conclusions. Smokers attending a specialist tobacco dependence treatment clinic who used more medications and for longer duration had higher abstinence rates.

Original languageEnglish (US)
Pages (from-to)114-119
Number of pages6
JournalPreventive Medicine
Volume42
Issue number2
DOIs
StatePublished - Feb 1 2006

Fingerprint

Tobacco Use Disorder
Smoking Cessation
Drug Therapy
Tobacco Products
Tobacco
Counseling
Smoking
Odds Ratio
Education
Therapeutics

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Steinberg, Michael B. ; Foulds, Jonathan ; Richardson, Donna L. ; Burke, Michael V. ; Shah, Pooja. / Pharmacotherapy and smoking cessation at a tobacco dependence clinic. In: Preventive Medicine. 2006 ; Vol. 42, No. 2. pp. 114-119.
@article{3d93c759102d44ddbf211679aa92cc1c,
title = "Pharmacotherapy and smoking cessation at a tobacco dependence clinic",
abstract = "Background. Tobacco dependence medications are effective, and combinations may offer advantages. This study evaluates abstinence rates among smokers treated in a tobacco specialist clinic with individual and/or group counseling plus combination pharmacotherapy. Methods. 790 smokers treated at the Tobacco Dependence Clinic in New Jersey from 2001-2003 and contacted 4 weeks after quit-date were studied. Patients received medications and behavioral interventions. Abstinence over the previous 7 days was evaluated at 4 weeks and 6 months. Patients lost to 6-month follow-up were considered still smoking. Results. Overall, 36{\%} of patients were abstinent at 6 months (20{\%} who used no medications, 37{\%} using one medication, 37{\%} using 2 medications, 42{\%} using 3 medications, and 42{\%} using 4+ medications) (P = 0.017). 27{\%} still used medications at 6 months, and had higher abstinence rates (65{\%}) than those who stopped their medications (27{\%}) (P < 0.001). Number of medications predicted abstinence at 4 weeks [adjusted odds ratios = 2.30 (95{\%} CI; 1.27-4.18) for 1 medication, 4.78 (2.72-8.40) for 2 medications, 5.83 (2.98-11.40) for 3 medications, and 11.80 (4.10-33.95) for 4+ medications]. Increasing age, increasing level of education, longer time after waking to first cigarette, more than 7 clinical contacts, and more medications used were related to higher abstinence at 6 months. Conclusions. Smokers attending a specialist tobacco dependence treatment clinic who used more medications and for longer duration had higher abstinence rates.",
author = "Steinberg, {Michael B.} and Jonathan Foulds and Richardson, {Donna L.} and Burke, {Michael V.} and Pooja Shah",
year = "2006",
month = "2",
day = "1",
doi = "10.1016/j.ypmed.2005.11.013",
language = "English (US)",
volume = "42",
pages = "114--119",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "2",

}

Pharmacotherapy and smoking cessation at a tobacco dependence clinic. / Steinberg, Michael B.; Foulds, Jonathan; Richardson, Donna L.; Burke, Michael V.; Shah, Pooja.

In: Preventive Medicine, Vol. 42, No. 2, 01.02.2006, p. 114-119.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pharmacotherapy and smoking cessation at a tobacco dependence clinic

AU - Steinberg, Michael B.

AU - Foulds, Jonathan

AU - Richardson, Donna L.

AU - Burke, Michael V.

AU - Shah, Pooja

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Background. Tobacco dependence medications are effective, and combinations may offer advantages. This study evaluates abstinence rates among smokers treated in a tobacco specialist clinic with individual and/or group counseling plus combination pharmacotherapy. Methods. 790 smokers treated at the Tobacco Dependence Clinic in New Jersey from 2001-2003 and contacted 4 weeks after quit-date were studied. Patients received medications and behavioral interventions. Abstinence over the previous 7 days was evaluated at 4 weeks and 6 months. Patients lost to 6-month follow-up were considered still smoking. Results. Overall, 36% of patients were abstinent at 6 months (20% who used no medications, 37% using one medication, 37% using 2 medications, 42% using 3 medications, and 42% using 4+ medications) (P = 0.017). 27% still used medications at 6 months, and had higher abstinence rates (65%) than those who stopped their medications (27%) (P < 0.001). Number of medications predicted abstinence at 4 weeks [adjusted odds ratios = 2.30 (95% CI; 1.27-4.18) for 1 medication, 4.78 (2.72-8.40) for 2 medications, 5.83 (2.98-11.40) for 3 medications, and 11.80 (4.10-33.95) for 4+ medications]. Increasing age, increasing level of education, longer time after waking to first cigarette, more than 7 clinical contacts, and more medications used were related to higher abstinence at 6 months. Conclusions. Smokers attending a specialist tobacco dependence treatment clinic who used more medications and for longer duration had higher abstinence rates.

AB - Background. Tobacco dependence medications are effective, and combinations may offer advantages. This study evaluates abstinence rates among smokers treated in a tobacco specialist clinic with individual and/or group counseling plus combination pharmacotherapy. Methods. 790 smokers treated at the Tobacco Dependence Clinic in New Jersey from 2001-2003 and contacted 4 weeks after quit-date were studied. Patients received medications and behavioral interventions. Abstinence over the previous 7 days was evaluated at 4 weeks and 6 months. Patients lost to 6-month follow-up were considered still smoking. Results. Overall, 36% of patients were abstinent at 6 months (20% who used no medications, 37% using one medication, 37% using 2 medications, 42% using 3 medications, and 42% using 4+ medications) (P = 0.017). 27% still used medications at 6 months, and had higher abstinence rates (65%) than those who stopped their medications (27%) (P < 0.001). Number of medications predicted abstinence at 4 weeks [adjusted odds ratios = 2.30 (95% CI; 1.27-4.18) for 1 medication, 4.78 (2.72-8.40) for 2 medications, 5.83 (2.98-11.40) for 3 medications, and 11.80 (4.10-33.95) for 4+ medications]. Increasing age, increasing level of education, longer time after waking to first cigarette, more than 7 clinical contacts, and more medications used were related to higher abstinence at 6 months. Conclusions. Smokers attending a specialist tobacco dependence treatment clinic who used more medications and for longer duration had higher abstinence rates.

UR - http://www.scopus.com/inward/record.url?scp=32144455688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32144455688&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2005.11.013

DO - 10.1016/j.ypmed.2005.11.013

M3 - Article

VL - 42

SP - 114

EP - 119

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 2

ER -